Page last updated: 2024-08-24

fluorodeoxyglucose f18 and 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide

fluorodeoxyglucose f18 has been researched along with 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eskola, O; Grénman, R; Komar, G; Lehtiö, K; Levola, H; Lindholm, P; Minn, H; Seppälä, J; Seppänen, M; Sipilä, H; Solin, O1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide

ArticleYear
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11

    Topics: Adult; Aged; Chemoradiotherapy; Etanidazole; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed; Young Adult

2014